| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| JENNISON ASSOCIATES LLC | 10% | +6% | $230,991,369 | +$16,837,739 | 12,254,119 | +7.9% | Jennison Associates LLC | 30 Sep 2025 |
| PRUDENTIAL FINANCIAL INC | 10% | $158,869,590 | 11,954,070 | PRUDENTIAL FINANCIAL INC | 31 Mar 2025 | |||
| Frazier Life Sciences VIII, L.P. | 7.5% | $141,578,961 | 8,943,712 | Patrick J. Heron | 18 Aug 2025 | |||
| Polar Capital Holdings Plc | 4.2% | -24% | $79,252,452 | -$26,911,047 | 5,006,472 | -25% | Polar Capital Holdings Plc | 30 Jun 2025 |
As of 30 Sep 2025, 234 institutional investors reported holding 125,772,833 shares of Arcutis Biotherapeutics, Inc. - Common Stock (ARQT). This represents 105% of the company’s total 120,138,422 outstanding shares.
The largest institutional shareholders of Arcutis Biotherapeutics, Inc. - Common Stock (ARQT) together control 88% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| JENNISON ASSOCIATES LLC | 10% | 12,254,119 | +10% | 0.13% | $230,990,144 |
| Rubric Capital Management LP | 8.9% | 10,749,457 | 0% | 2.7% | $202,627,264 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 8.7% | 10,478,000 | -9.2% | 6% | $197,510,300 |
| Frazier Life Sciences Management, L.P. | 8.2% | 9,874,511 | 0% | 5.6% | $186,134,532 |
| BlackRock, Inc. | 7.1% | 8,573,995 | +0.48% | 0% | $161,619,806 |
| VANGUARD GROUP INC | 5.9% | 7,146,090 | +1.4% | 0% | $134,703,797 |
| Polar Capital Holdings Plc | 4.4% | 5,298,754 | +5.8% | 0.48% | $99,881,513 |
| STATE STREET CORP | 3.9% | 4,641,315 | +2.5% | 0% | $87,488,788 |
| GILDER GAGNON HOWE & CO LLC | 3.7% | 4,429,108 | +6.6% | 0.85% | $83,488,686 |
| MORGAN STANLEY | 3.6% | 4,276,394 | -0.88% | 0% | $80,610,030 |
| UBS Group AG | 2.5% | 2,948,438 | +0.36% | 0.01% | $55,578,057 |
| GEODE CAPITAL MANAGEMENT, LLC | 2.2% | 2,606,465 | +0.93% | 0% | $49,139,527 |
| JANUS HENDERSON GROUP PLC | 2% | 2,398,031 | +5.9% | 0.02% | $45,178,904 |
| FRANKLIN RESOURCES INC | 1.9% | 2,311,019 | -15% | 0.01% | $43,562,708 |
| Pivotal bioVenture Partners Investment Advisor LLC | 1.8% | 2,120,508 | 0% | 23% | $39,971,576 |
| D. E. Shaw & Co., Inc. | 1.8% | 2,118,713 | -2% | 0.03% | $39,937,740 |
| Perpetual Ltd | 1.7% | 2,024,606 | +7534% | 0.47% | $38,163,823 |
| Ensign Peak Advisors, Inc | 1.7% | 1,993,055 | -0.42% | 0.06% | $37,569,087 |
| GOLDMAN SACHS GROUP INC | 1.5% | 1,804,988 | -4.5% | 0% | $34,024,024 |
| AMERICAN CENTURY COMPANIES INC | 1.4% | 1,662,470 | -3.6% | 0.02% | $31,337,590 |
| Nuveen, LLC | 1.1% | 1,370,356 | +79% | 0.01% | $25,831,211 |
| GW&K Investment Management, LLC | 0.98% | 1,172,041 | -15% | 0.2% | $22,093,000 |
| Driehaus Capital Management LLC | 0.91% | 1,097,004 | +1% | 0.15% | $20,678,525 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 0.83% | 999,434 | +3.6% | 0% | $18,839,331 |
| NORTHERN TRUST CORP | 0.78% | 940,202 | +1.2% | 0% | $17,722,808 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 2,390,714 | $69,342,504 | -$15,202,042 | $29.04 | 22 |
| 2025 Q3 | 125,772,833 | $2,369,578,876 | -$12,687,586 | $18.85 | 234 |
| 2025 Q2 | 127,080,415 | $1,781,069,063 | +$21,637,099 | $14.02 | 228 |
| 2025 Q1 | 125,020,171 | $1,954,461,834 | -$63,284,148 | $15.64 | 238 |
| 2024 Q4 | 128,700,196 | $1,792,792,113 | +$16,085,473 | $13.93 | 205 |
| 2024 Q3 | 128,466,844 | $1,196,656,614 | +$14,233,673 | $9.30 | 187 |
| 2024 Q2 | 126,510,125 | $1,176,681,365 | +$21,044,712 | $9.30 | 185 |
| 2024 Q1 | 109,404,335 | $1,084,075,908 | +$267,002,535 | $9.91 | 125 |
| 2023 Q4 | 159,312 | $515,355 | -$27,195 | $3.23 | 3 |
| 2023 Q3 | 67,067,552 | $356,213,729 | -$29,952,633 | $5.31 | 132 |
| 2023 Q2 | 71,670,340 | $683,083,308 | -$6,790,555 | $9.53 | 132 |
| 2023 Q1 | 71,586,458 | $787,439,086 | +$44,291,408 | $11.00 | 139 |
| 2022 Q4 | 65,585,911 | $970,655,158 | +$88,099,904 | $14.80 | 136 |
| 2022 Q3 | 59,305,828 | $1,133,330,532 | +$193,854,925 | $19.11 | 135 |
| 2022 Q2 | 49,064,239 | $1,045,579,402 | +$17,638,645 | $21.31 | 110 |
| 2022 Q1 | 48,181,520 | $927,366,760 | +$37,239,484 | $19.26 | 103 |
| 2021 Q4 | 45,692,425 | $947,657,713 | -$2,868,603 | $20.74 | 86 |
| 2021 Q3 | 45,669,050 | $1,090,746,157 | +$4,204,309 | $23.89 | 100 |
| 2021 Q2 | 45,448,921 | $1,240,158,476 | -$38,012,543 | $27.29 | 99 |
| 2021 Q1 | 46,828,892 | $1,354,646,559 | +$171,081,997 | $28.93 | 91 |
| 2020 Q4 | 40,821,727 | $1,148,322,120 | +$134,359,690 | $28.13 | 77 |
| 2020 Q3 | 34,765,777 | $1,018,640,387 | +$28,883,436 | $29.30 | 60 |
| 2020 Q2 | 33,776,828 | $1,021,408,758 | +$33,104,673 | $30.24 | 55 |
| 2020 Q1 | 32,683,150 | $973,960,747 | +$973,281,288 | $29.80 | 48 |